Novel polymorphic forms of bosentan and processes for their preparation aredisclosed. Further, pharmaceutical compositions comprising said polymorphicformsand the use of said compositions in the treatment of patientssuffering from endothelinreceptor mediated disorders, for example,cardiovascular disorders such ashypertension, pulmonary hypertension, ischemia, vasospasm and angina pectorisare disclosed.